In Brazil, envenomation by Bothrops pitvipers is responsible for over 73% of snakebites, and their venom is a rich source of proteolytic enzymes. Most studies have demonstrated that Bothrops jararaca venom acts on macromolecular substrates, causing an imbalance in the victim's hemostatic system. In contrast, fewer studies have examined the proteolytic activity on small molecules such as peptides. In this study, we used a set of bioactive peptides (insulin B chain, Met-enkephalin, Leu-enkephalin, neuropeptide Y, peptide YY, pancreatic polypeptide, substance P and somatostatin) to identify new peptide substrates for the metallopeptidases and serine peptidases from the B. jararaca venom. The majority of these peptides were substrates for the venom, but neuropeptide Y and pancreatic polypeptide presented higher hydrolyses rates. Although most of the peptides were simultaneously substrates for both classes of proteases, serine peptidases were the most active. Substance P was an exclusive substrate for metallopeptidases, while somatostatin was a selective substrate for serine peptidases. The neutralizing efficacy of the bothropic antivenom produced by the Butantan Institute was also assessed and found to totally prevent substance P hydrolysis, whereas somatostatin cleavage was not inhibited. Thus, the antivenom effectively inhibited metallopeptidase activity, but did not neutralize some of the serine peptidases. These results indicate that, in addition to cleaving proteins, the proteolytic enzymes from this venom also hydrolyze bioactive peptides, and this peptidase activity could effectively contribute to some of the many dire manifestations of envenomation.
Introduction
Snakebite is a public health problem in tropical countries and, in Brazil, over 27,000 accidents are reported every year, with Bothrops jararaca being responsible for most of the cases (Minist erio da Saúde, 2009 ). The administration of specific antivenom is the standard treatment for snakebite, as recommended by the World Health Organization (World Health Organization, 2010) . Thus, improvement in production, storage, distribution, as well as further studies on quality and safety of the sera produced, is of great importance to improve the current scenario.
Despite the great variety of components present in the venom from Bothrops species, proteomics and transcriptomics studies demonstrated that the Bothrops jararaca venom (BjV) is composed mainly of proteases (Fox and Serrano, 2008; Goncalves-Machado et al., 2016; Nicolau et al., 2017) . Also, SVMPs (snake venom metalloproteases) and SVSPs (snake venom serine proteases) are considered major toxins of the BjV. These enzymes are responsible for some of the severe symptoms described in patients, such as: strong local pain, bruising and blistering on the affected limb, spontaneous systemic bleeding in various organs, clotting disturbances, hypotension, hemostatic disorders, shock and renal failure, when some of those symptoms can lead to death (Minist erio da Saúde, 2009) .
Classically, it has been attributed to SVMP mainly the role of hemorrhagic factors, degrading proteins such as laminin, fibronectin and collagen type IV (Markland and Swenson, 2013) while SVSPs are enzymes which affect the hemostatic system, acting on a variety of components of the coagulation cascade and on the fibrinolytic and kallikreinekinin systems (Serrano and Maroun, 2005) . However, recent studies have demonstrated that SVMP might have an even bigger part in the envenomation than was firstly thought, exerting several activities historically attributed to SVSPs like kininogenase and hypofibrinogenemia activities (Okamoto et al., 2014; Yamashita et al., 2014) . It is also important to know that in addition to SVMPs and SVSPs, classified as endopeptidases, the presence of exopeptidases has also been reported as components of snake venoms. In this way, snake venom dipeptidyl peptidase IV and rhiminopeptidase A -serine peptidases presenting aminopeptidase activity e have both already been described in several snake venoms (Aird, 2008; Ogawa et al., 2007 Ogawa et al., , 2006 Vaiyapuri et al., 2010) , even in BjV (Gasparello-Clemente and Silveira, 2002) . Snake venom proteases are intensively explored, however, most studies usually focus on proteins as substrates. In contrast, little is known about the activity of these enzymes on biological active peptides that can also be important in envenomation. Notwithstanding, some studies using synthetic substrates, such as chromogenic and fluorescent peptides, can be found in the literature (Faiz et al., 1996; Kuniyoshi et al., 2012; Porto et al., 2007) . Although less explored in the literature, we can hypothesized that endogenous peptides can be hydrolyzed by the venom. This inactivation/activation is of utmost importance, since these intracellular and intercellular signaling molecules regulate neural, endocrine and immune processes (Bhat et al., 2015) .
Considering that snakebite is a public health issue, and that there is need for further information about BjV peptidase activity, we searched for biological active peptides as new substrates for metallopeptidases and serine peptidases in this venom, trying to understand some features of the bothropic envenomation. Furthermore, as the serum therapy is the recommended and used treatment for human envenomation, the efficacy of the antibothropic serum produced by the Butantan Institute was assessed to block these new activities.
Materials and methods

Reagents
Ethylenediaminetetracetic acid (EDTA), phenylmethanesulfonyl fluoride (PMSF), neuropeptide Y (part number N5017), peptide YY (P1306), pancreatic polypeptide (P6410), substance P (S6883), insulin B chain (I6383), somatostatin (S9129), Met-enkephalin (M6638) and Leu-enkephalin (L9133) from SigmaeAldrich. Acetonitrile and trifluoroacetic acid (TFA) were purchased from J.T. Baker.
Venoms and antivenoms
The lyophilized venom of Bothrops jararaca was provided by the Venom Section of the Butantan Institute. Stock solution was prepared in 50 mM sodium phosphate, 50 mM NaCl, pH 7.4 at 2.0 mg/ mL final concentration. The bothropic antivenom (BAV) produced by the hyperimmunization of horses with venoms from B. alternatus (12.5%), B. jararaca (50%), B. jararacussu (12.5%), B. moojeni (12.5%) and B. neuwiedi (12.5%) was obtained from the Hyperimmune Plasmas Processing Section, Butantan Institute. The antivenom used (batch no. 0506110) had a protein concentration of 1.8 g/dL and each milliliter was able to neutralize 6.61 mg of B. jararaca venom (lethality test in mice). Protein measurements were made using a Quick Start Bradford assay kit (Bio Rad Protein Assay) according to the manufacturer's instructions.
HPLC analysis of bioactive peptides hydrolysis by BjV and its inhibition by EDTA and PMSF
BjV (2 mg) was incubated in 50 mM Tris-HCl, pH 7.4 containing 50 mM NaCl,, at 37 C for 30e120 min in a final volume of 100 mL, in order to maintain the hydrolysis levels below 10%, with the following bioactive peptides (25e75 mM): neuropeptide Y (NPY); peptide YY (PYY); pancreatic polypeptide (PP); substance P (SP); insulin B chain (IBC), somatostatin (STT); Leu-enkephalin (Leu-E) and Met-enkephalin (Met-E). The hydrolysis was analyzed using reverse-phase HPLC (Prominence, Shimadzu, Japan) at 0.1% trifluoroacetic acid (TFA) in water, as solvent A; and acetonitrile and solvent A (9:1), as solvent B. The separations were performed at a flow rate of 1 mL/min using a Restek Ultra C-18 column (4.6 Â 150 mm) and a 20e60% gradient of solvent B over 20 min. In all cases, elution was followed by the measurement of ultraviolet absorption (214 nm). The inhibition of peptidase activity was determined using 100 mM EDTA and 3 mM of PMSF (the same volume of ethanol was used in the control group). The specific activities were expressed in mmoles of hydrolyzed substrate per mg of venom per minute (mmol/mg/min). All assays were performed in triplicate and the results were expressed as the mean ± SD.
Neutralization by antivenom in vitro
The ability of the antivenom to neutralize the peptidase activity of the venom was estimated as previously described (Kuniyoshi et al., 2012) . Briefly, the antivenom (10 mL) was pre incubated for 30 min with 2 mg of BjV at room temperature, and this was followed by the addition of each bioactive peptide. BAV dose used for neutralization assays was stipulated through enzymatic neutralization curve (Supplementary Fig. 1 ) using selective FRET substrates for serinepeptidases (Abz-Ser) and metallopeptidases (Abz-Metal) (Kuniyoshi et al., 2012) . The analysis was made at HPLC using a C-18 column, as described above, the experiments were conducted in triplicate and the results were expressed as the meanþSD (item 2.3).
Mass spectrometric analysis
The fragments generated by the hydrolysis of bioactive peptides using BjV were resuspended in 0.1% formic acid and analyzed in an Easy-nLC II nano HPLC system (Thermo Fisher Scientific) coupled to an LTQ-Orbitrap Velos (Thermo Fisher Scientific) through a nanoelectrospray ion source. The separation was carried out in a 10 cm column (75 mm I.D. x 350 mm O.D.) packed in-house with 5 mm Jupiter C-18 beads (Phenomenex). Peptides were eluted with a linear gradient of 5e95% acetonitrile, in 0.1% formic acid at a flow rate of 200 nL/min over 15 min. The nanoelectrospray voltage was set to 2.1 kV, the source temperature to 200 C and the spectrometer was operated in data-dependent mode where the 5 most intense peaks were selected for CID fragmentation after acquiring each full scan. The settings for the spectrometer were defined as:
high-resolution full MS parameters (1 mscan; full MS mass range m/ z of 200À2000 with a resolution of 60,000 and a target value of 1 Â 10 4 ions; max injection time ¼ 100 ms). For fragment scans the settings were: isolation window of 2 Da, max list size of 500, exclusion duration time window of 15 s, a minimum signal of 5,000, activation time ¼ 10 ms and normalized collision energy ¼ 35%.
The raw data files were submitted to searches using PEAKS Studio (version 7, Bioinformatics Solution, Waterloo, Canada) (Zhang et al., 2012) . The search parameters were: no enzyme specificity; precursor mass tolerance set to ±10 ppm and a fragment ion mass tolerance of ±0.5 Da; oxidized methionine (M þ15.994915 Da) and amidation (À0.98 Da) were set as variable modifications. The identified peptides were then sorted by their Average Local Confidence (ALC) > 85% to select the best spectra to annotate.
Results
HPLC analysis of bioactive peptide hydrolysis by BjV using EDTA and PMSF
Initially we examined the hydrolysis of the IBC, STT, SP, PP, NPY, PYY, Leu-E and Met-E by BjV and noted that NPY and PP were by far the best substrates for this venom, with hydrolysis rates around 40 times higher than for SP, the least hydrolyzed substrate. This observation is interesting since these two peptides belong to the neuropeptide Y family. NPY and PP were preferentially hydrolyzed by serine peptidases, with inhibition by PMSF varying from 59.5 ± 13% and 81 ± 1.4% when compared to positive controls. Somatostatin was hydrolyzed exclusively by serine peptidases, since PMSF totally inhibited its cleavage. In contrast, substance P was cleaved only by metallopeptidases with 100% inhibition by EDTA, there was no inhibition by PMSF (Fig. 1) . Finally, Leu-E and Met-E were not hydrolyzed by BjV, even after prolonged incubation. All specific activities rates along with peptidase activity of BjV towards angiotensin I are shown in Supplementary Table 1.
Neutralization by antivenom
The commercial antivenom produced by the Butantan Institute (BAV) almost completely neutralized the cleavage of substance P, which is a substrate only for metallopeptidases. On the other hand, BAV did not prevent the hydrolysis of somatostatin, a specific substrate for venom serine peptidases (<10% neutralization). The hydrolysis of pancreatic polypeptide (PP) and peptide YY was well neutralized by BAV, reaching 89 ± 2.1% inhibition; this was not the case for the neuropeptide Y, since the maximum inhibition obtained was 46.5 ± 0.7%. Insulin B chain hydrolysis was also well neutralized by BAV, with 73.5 ± 4.9% inhibition (Fig. 1). 
Determination of cleavage points by mass spectrometry
The fragments of the biological active peptides, substrates for BjV, were manually collected ( Supplementary Fig. 2 ) and analyzed by mass spectrometry, as shown in Fig. 2A (neuropeptide Y fragments, Supplementary Fig. 3 ) and Fig. 2B (IBC, STT and SP). It is important to note that only fragments with average local confidence (ALC) !85% were considered for analysis. Several NPY, PYY and PP fragments presented Arg or Tyr residues at the P1 position (Schechter and Berger, 1967) , indicating trypsin and chymotrypsinlike activities, since the hydrolysis of these substrates was preferentially inhibited by PMSF (Fig. 1) . Also, the tripeptide C-terminus moiety (Gln/Pro-Arg-Tyr), present in all members of the neuropeptide Y family-and very important for performing their biological activities -was released in all three peptides by BjV. However, we observed a complex hydrolysis pattern of these three substrates, indicating that the BjV peptidases together can cleave sequences with hydrophobic, polar or charged amino acids at the P1 position. The number of different fragments generated from members of the neuropeptide Y family varied between 10 and 12 ( Fig. 2A) .
Somatostatin was cleaved at least at two points by serine peptidases, since PMSF totally inhibited formation of the FFWK fragment (Fig. 2B) , which was the only one detected by mass spectrometry. Thus, somatostatin was cleaved between N-F and K-T, showing that BjV serine peptidases present a broad specificity of hydrolysis.
Substance P was cleaved in several points by metallopeptidases, with at least six fragments detected by mass spectrometry analysis. Only the N-terminal region of the peptide, RPKPQQ, was left intact (Fig. 2B) .
Insulin B chain was hydrolyzed by both classes of peptidases, generating at least eight different fragments. Two out of three metallopeptidase cleavages detected in the presence of PMSF occurred when Leu was at the P1 0 position (Ala-Leu and Tyr-Leu), which is in agreement with the specificity of SVMPs, such as bothropasin and atrolysin (Paes Leme et al., 2011). Again, one serine peptidase cleavage observed in the presence of EDTA, occurred when Tyr was at the P1 position, indicating chymotrypsin-like activity (Fig. 2B) .
Comparison of the points of IBC cleavage when using BAV and EDTA, demonstrated that the hydrolysis between Ala-Leu residues was completely blocked by both, indicating an effectiveness of the commercial product to block metallopeptidases (Fig. 2B ).
Discussion
Considering that identifying substrates is a crucial step to gain insights into the precise functions of venom peptidases and their mechanisms of action in biology and envenomation, we decided to study the possible hydrolysis of bioactive peptides by BjV. The main peptide substrates studied here are involved with the maintenance of energy homeostasis, blood pressure regulation, pain sensation and as regulators of glucose/insulin/glucagon levels. Surprisingly, the biological active peptides were most susceptible to serine peptidase degradation, instead of metallopeptidases, which are the most abundant toxins in BjV. This fact could be associated to the much higher autolysis rate described for SVMP than to SVSP, even in the presence of specific inhibitors (Nicolau et al., 2017) . Although BjV hydrolyzed most of the peptides studied, not all were cleaved, as bradykinin and the enkephalins, which indicate a sort of selectivity of these enzymes toward some peptides, such as the members of the neuropeptide Y family. This family consists of 36 amino acid peptides exhibiting C-terminal amidation and includes the neuropeptide Y, peptide YY and the pancreatic polypeptide (Conlon, 2002) . All three peptides were preferentially hydrolyzed by serine peptidases from BjV, and despite the 70% identity among them, the hydrolysis of PYY was almost 10 times lower than NPY and PP. Moreover, the serum neutralization levels varied greatly among them and the lowest level of inhibition was obtained using the NPY as substrate. Thus, the results obtained with the members of the neuropeptide Y family demonstrate that at least one serine peptidase isoform from the BjV was not blocked by commercial antivenoms produced by the Butantan Institute.
The C-terminal amidated tyrosine of the NPY peptide family is important for their biological activity, which is responsible for binding on its receptors, and the removal of tyrosine residue causes the loss of their in vivo functions (Grundemar and Hakanson, 1990) . The results showed that BjV is able to remove the C-terminus tripeptide of the NPY hormone family after incubation with the venom, indicating that the BjV is able to inactivate these peptides. The effective hydrolysis and inactivation of neuropeptide Y and pancreatic polypeptide by the whole BjV in vitro could be associated with hypotension, since the intact members from the neuropeptide Y family have their in vivo activities related to vasoconstriction (Hodges and Sparks, 2014) . It is important to note that a family of peptides with ACE inhibitory activity, the BPPs (BradykininPotentiating Peptides), is present in the venom of B. jararaca (Camargo et al., 2012) . Also, while bradykinin is totally resistant and angiotensin-I is degrade by BjV (Kuniyoshi et al., 2012) , it contains a serine peptidase able to release bradykinin from the high molecular weight kininogen (KN-BJ) (Serrano et al., 1998) . Together, the data presented here comes to contribute to the better understand the mechanisms of hypotension observed in cases of human envenomation by B. jararaca.
Pancreatic polypeptide and peptide YY can also inhibit insulin secretion (Boey et al., 2006; Deng and Whitcomb, 2006) , and the hydrolysis of these molecules by BjV could promote unbalance of energy during the envenomation, such as alterations in plasmatic glucose levels of mice experimentally envenomed by Bothrops jararacussu venom (Zeni et al., 2007) . However, the glucose alterations associated to envenomation by Bothrops alternatus are controversial in the literature. Mello et al. (2010) observed glucose increment on rats urine envenomed by Bothrops alternatus, while Dias et al. (2012) observed no significant alterations in glucose levels in the blood of anesthetized dogs. In this way, our results, in association with this controversy in the literature, indicate that this phenomenon deserves further studies in the future.
Substance P is the most potent tachykinin ligand for the highaffinity neurokinin-1 receptor, and this peptide was the only substrate exclusively hydrolyzed by BjV metallopeptidases. SP was first described as an antinociceptive peptide that is opioid-receptor dependent (Hall and Stewart, 1983; Yeomans and Proudfit, 1992) but later was also characterized as an important factor in the cardiovascular system, modulating heart rate and blood pressure (Mistrova et al., 2016) . The substance P antinociceptive activity is controversial, and it seems to be dependent on the dose used (De Felipe et al., 1998; Frederickson et al., 1978; Oehme et al., 1980) . The mass spectrometry analysis demonstrated that the only intact fragment of SP was SP 1-6 , and this fragment was reported to be unable to activate the neurokinin-1 receptor (Vigna, 2001) , indicating the inactivation of substance P by the metallopeptidases present in the BjV. Okamoto et al. (2014) isolated a P-I SVMP from the venom of B. moojeni with proteolytic activity over substance P, and interestingly, three of the four cleavage points detected in this work were present in their work, indicating the presence of a BmooMPa-I like SVMP in the BjV. Another metallopeptidase called lebetase I, isolated from the venom of Vipera lebetina also hydrolyzed substance P and one of the sites (Gly-Leu) coincided with our results with BjV (Trummal et al., 2000) . The BAV was able to practically fully block the SP hydrolysis, similar to EDTA, a metalloprotease inhibitor, showing the efficacy of the commercial product to block the metalloproteases of the BjV.
SP is a known substrate for DPP IV, and the presence of this serine protease has already been detected in several snake venoms (Aird, 2008) . Also, a DPP IV activity was measured in the BjV when using a synthetic substrate (Gasparello-Clemente and Silveira, 2002) . However, this activity was not observed using the methodology described in the present study using SP as substrate, which shows its degradation by metallopetidases. Thus, we could hypothesize that the SP degrading activity could be related to a preferential metallopeptidase activity when using the total BjV.
Some studies demonstrated that somatostatin has an antinociceptive effect when injected in different mammal models, and that it has been able to inhibit several kinds of pain. Therefore, the degradation of this peptide by BjV could be related to the persistent local pain described on the envenomed patients (Rai et al., 2015) . The BAV was not able to block the STT hydrolysis, and since the PMSF, which is a serine proteases inhibitor, fully blocked the STT hydrolysis by the venom, once more we assume that the BAV is unable to block at least one serine peptidase from this venom. An identical phenomenon, that is, the failure of the commercial antivenom to block serine peptidases, was observed when we studied the hydrolysis of dynorphin A, angiotensin I and FRET substrates selective for the metallopeptidases and serine peptidases from BjV (Kuniyoshi et al., 2012) .
Although Leu-and Met-enkephalins have been characterized as substrates for the Naja atra venom (Anderson et al., 1998; Anderson and Dufton, 1997) this was not the case for BjV which, differently from the Naja venom, does not present a neurotoxic effect during the envenomation process.
Other studies have already demonstrated that the insulin B chain can be degraded by metallo-and serine proteases from BjV (Mandelbaum et al., 1967; Tanizaki et al., 1989) . Regarding the specificity of BjV proteases upon the oxidized insulin B chain, our work showed identical cleavage points when compared with results described by both metalloproteases bothropasin and jararhagin, Ala-Leu and Tyr-Leu, and similar cleavage point by the serine protease BPA, with hydrophobic aromatic residue at P1 position (Fox et al., 1986) . This substrate was hydrolyzed by both classes of proteases and it clearly showed a good BAV neutralization of metallopeptidases, as the Ala-Leu cleavage point was totally abolished. In contrast, the Tyr-Leu bond hydrolysis by both serine and metallopeptidases of the BjV is partially inhibited by BAV and, thus, we believe that the remaining activity is due to the lack of neutralization of the SVSPs responsible for this cleavage.
Although there is no information in the literature, we cannot rule out the possibility that the fragments generated from the hydrolysis of the peptides used in the present study may present biological activities.
Conclusions
In conclusion, our study presents new peptide substrates for the most abundant toxins in the BjV, the snake venom metallo and serine peptidases. The data presented in this study may contribute to the better understanding of the envenomation process, since these peptides show a wide spectrum of biological activities acting on the neural, endocrine, immune and gastric processes. Considering that these peptides are well degraded in vitro by the whole BjV, it could be expected, likewise, that they will be degraded in vivo. However, it is important to stress that in vitro techniques have limitations, and this work cannot confirm possible alterations in these biological peptides concentration in vivo and this possibility certainly must be studied in the future. Finally, aside from the effective inhibition of metallopeptidases, the Brazilian antivenom used for human therapy was insufficient for the full in vitro neutralization of the serine peptidase activities here demonstrated, indicating that further studies about SVSPs immunogenicity are necessary to significantly improve the efficacy of the anti-bothropic serum.
